Old Port Advisors Raises Stake in Colgate-Palmolive (NYSE:CL)

Old Port Advisors raised its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 7.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,589 shares of the company’s stock after purchasing an additional 170 shares during the period. Old Port Advisors’ holdings in Colgate-Palmolive were worth $235,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Advisor OS LLC increased its position in Colgate-Palmolive by 4.5% during the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock valued at $228,000 after buying an additional 101 shares in the last quarter. D Orazio & Associates Inc. grew its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after acquiring an additional 108 shares during the last quarter. Fiducient Advisors LLC grew its stake in shares of Colgate-Palmolive by 5.2% in the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after acquiring an additional 110 shares during the last quarter. Wealthspire Advisors LLC increased its holdings in shares of Colgate-Palmolive by 3.0% during the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after acquiring an additional 111 shares in the last quarter. Finally, Sequoia Financial Advisors LLC boosted its stake in Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $90.55 on Friday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock has a 50-day simple moving average of $93.46 and a two-hundred day simple moving average of $98.46. The firm has a market capitalization of $73.98 billion, a PE ratio of 25.95, a P/E/G ratio of 3.31 and a beta of 0.43. Colgate-Palmolive has a 52-week low of $79.52 and a 52-week high of $109.30.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.21%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.34% of the stock is owned by company insiders.

Analysts Set New Price Targets

CL has been the subject of several recent analyst reports. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. TD Cowen lowered their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. Finally, Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $105.11.

Read Our Latest Stock Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.